RPGR gene therapy presents challenges in cloning the coding sequence
<p><strong>Introduction:</strong> Currently, there are three Phase I/II clinical trials based on gene therapy ongoing to test different AAV.RPGR or deleted RPGR vectors on patients affected by X-linked retinitis pigmentosa. These three vectors differ in the adeno-associated viral (...
Egile Nagusiak: | Martinez-Fernandez De La Camara, C, Cehajic-Kapetanovic, J, MacLaren, RE |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
Taylor and Francis
2019
|
Antzeko izenburuak
-
Clinical applications of microperimetry in RPGR-related retinitis pigmentosa: a review
nork: Buckley, TMW, et al.
Argitaratua: (2021) -
Characterizing visual fields in RPGR related retinitis pigmentosa using octopus static-automated perimetry
nork: Buckley, TMW, et al.
Argitaratua: (2022) -
Association of a novel intronic variant in RPGR with hypomorphic phenotype of x-linked retinitis pigmentosa
nork: Cehajic-Kapetanovic, J, et al.
Argitaratua: (2020) -
Microperimetry as an outcome measure in RPGR-associated retinitis pigmentosa clinical trials
nork: Taylor, LJ, et al.
Argitaratua: (2023) -
Low luminance visual acuity and low luminance deficit in choroideremia and RPGR-associated retinitis pigmentosa
nork: Wood, LJ, et al.
Argitaratua: (2021)